AllPennyStocks.com IRD Stock Hits Over 5-Year Highs – Opus Genetics Experimental Therapy Shows Early Promise In Retinal Diseases Trial
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

IRD Stock Hits Over 5-Year Highs – Opus Genetics Experimental Therapy Shows Early Promise In Retinal Diseases Trial

Researchers observed structural improvements in the retina in four of five patients being evaluated in a Phase 1/2 study

Other Penny Stock Movers

SaaS Provider Surges 22% on Profitability Targets
BC Copper-Gold Explorer Surges 40% on Maiden Drill Visuals
Why Mining Giants Keep Buying the Ground Next Door
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top